Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 14, 2005; 11(38): 6031-6037
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6031
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6031
Figure 1 Frequency of the TT genotype at position -159 of the CD14 gene in patients with chronic hepatitis C infection, chronic alcohol abuse, and controls.
The TT genotype was significantly more frequent in alcoholics with cirrhosis (25/62; [40.3%]), compared to alcoholics without clinical or sonomorphological signs of cirrhosis (28/118; [23.7%]; P = 0.020) and controls (55/247 [22.3%]; P = 0.006). In contrast, in HCV patients with no or only mild fibrosis (stage 1 or 2) and patients with prominent fibrosis or cirrhosis (stage 3 or 4) the frequency of the TT genotype was not significantly different (20/85 [23.5%]vs 9/36 [25.5%]).
- Citation: Meiler C, Mühlbauer M, Johann M, Hartmann A, Schnabl B, Wodarz N, Schmitz G, Schölmerich J, Hellerbrand C. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 2005; 11(38): 6031-6037
- URL: https://www.wjgnet.com/1007-9327/full/v11/i38/6031.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i38.6031